Renin-Angiotensin System Blockers and the COVID-19 Pandemic – At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
A.H. Jan Danser, Murray Epstein, Daniel Batlle
DOI: 10.1161/HYPERTENSIONAHA.120.15082
Online veröffentlicht am 25.03.2020 in "Hypertension"
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers – What Is the Evidence?
A.B. Patel, A. Verma
DOI: 10.1001/jama.2020.4812
Online veröffentlicht am 24.03.2020